AVAI (Avai Bio) Total Stockholders Equity: $-2.79 Mil (As of Dec. 2025)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.16
! 3 Warning Signs
View Full Analysis

What is Avai Bio Total Stockholders Equity?

Avai Bio AVAI +32.46% 24 Total Stockholders Equity is $-2.79 Mil as of Dec. 2025. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Avai Bio's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $-2.79 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Avai Bio's Book Value per Share for the quarter that ended in Dec. 2025 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Avai Bio's Debt-to-Equity for the quarter that ended in Dec. 2025 was -0.56.

Avai Bio  (OTCPK:AVAI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Avai Bio's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-2.794-0.027)/138.032
=-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Avai Bio's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.568 + 0) / -2.794
=-0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avai Bio Total Stockholders Equity Related Terms

Avai Bio Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Avai Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avai Bio Total Stockholders Equity Chart

Avai Bio Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Stockholders Equity
Get a 7-Day Free Trial -0.33 -0.41 -0.63 -1.47 -1.56

Avai Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.14 -1.56 -1.99 -2.30 -2.79
AVAI
24GF Score
Avai Bio Inc AVAI
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $-2.79 Mil mean?
Avai Bio (AVAI) has a Total Stockholders Equity of $-2.79 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Avai Bio and its competitors.
Is Avai Bio's Total Stockholders Equity too high?
Avai Bio's current Total Stockholders Equity is $-2.79 Mil. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Total Stockholders Equity compare to IPM and RCT?
Avai Bio's Total Stockholders Equity of $-2.79 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Software company?
A good Total Stockholders Equity depends on the Software industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Avai Bio and its competitors. Avai Bio's current Total Stockholders Equity is $-2.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Total Stockholders Equity of $-2.79 Mil. The current Total Stockholders Equity is $-2.79 Mil. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Avai Bio (AVAI), the current Total Stockholders Equity is $-2.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price